Seres Therapeutics Stock (NASDAQ: MCRB)
|Day Range6.29 - 6.49||52 Wk Range2.5 - 9||Open / Close6.32 / -||Float / Outstanding87.9M / 124.1M|
|Vol / Avg.363.8K / 1.1M||Mkt Cap803.4M||P/E-||50d Avg. Price5.56|
|Div / Yield-||Payout Ratio-||Total Float87.9M||EPS-0.7|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.
The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Piper Sandler on Wednesday, September 7, 2022. The analyst firm set a price target for 9.00 expecting MCRB to rise to within 12 months (a possible 39.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $6.475 last updated Today at October 4, 2022, 7:17 PM UTC.
There are no upcoming dividends for Seres Therapeutics.
Seres Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Seres Therapeutics.
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.